Malignant Peritoneal and Retroperitoneal Neoplasm

Malignant Peritoneal and Retroperitoneal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

631 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 163
Recruiting: 76
Ph III recruiting: 8
Growth YoY: −39.1%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 31.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (92)

clinicaltrialsPublishedShowing 101–150 of 289 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05200260	Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer	recruiting	Phase 2	220	Shanghai Gynecologic Oncology GroupOTHER_GOV	1	Feb 10, 2025	clinicaltrials
NCT03891576	Newton Study (NEW Dosing MainTenance Therapy Ovarian CaNcer)(Newton)	terminated	Phase 2	83	Mario Negri Institute for Pharmacological ResearchOTHER	2	Jan 17, 2025